Comprehensive diagnostic evaluation identifies HPV-associated squamous cell carcinoma in a patient with a pelvic mass
HPV Testing Helps Identify Source of Pelvic Squamous Cell Carcinoma
This case report describes a 55-year-old woman with a pelvic mass and a squamous cell carcinoma. The report highlights the utility of integr…
A single case report shows how combining imaging and HPV testing can help doctors identify the source of a pelvic tumor.
Dual immune checkpoint inhibition provides durable intracranial progression-free survival in melanoma patients with brain metastases
Dual immune therapy shows promise for melanoma brain metastases
This meta-analysis of 3,518 patients with cutaneous or mucosal melanoma brain metastases indicates that dual immune checkpoint inhibition pr…
Combining two immune therapies may offer more durable results for patients with melanoma that has spread to the brain.
Robot-assisted partial nephrectomy shows shorter warm ischemia time and less blood loss than open surgery
Robot-assisted Surgery Shows Faster Recovery for Kidney Tumor Removal
This meta-analysis of 333 patients with a tumor in a solitary kidney compared robot-assisted partial nephrectomy (RAPN) to open partial neph…
Robot-assisted surgery for kidney tumors may lead to less blood loss and faster hospital discharge compared to traditional open surgery.
Low CALLY index is associated with worse progression-free survival and overall survival in renal cell carcinoma
CALLY index helps predict survival for kidney cancer patients
This meta-analysis of five retrospective cohort studies indicates that a low C-reactive protein-albumin-lymphocyte (CALLY) index correlates …
A specific blood marker called the CALLY index may help doctors predict how well patients with kidney cancer will respond to treatment.
FDA Approves Talzenna (talazoparib) for Germline BRCA-Mutated HER2-Negative Breast Cancer
FDA Approves Talzenna, a Daily Pill for Some Inherited Breast Cancers
The FDA approved talazoparib (Talzenna) as a single agent for adults with deleterious or suspected deleterious germline BRCA-mutated HER2-ne…
The FDA approved Talzenna, a once-daily pill, for adults with advanced or metastatic breast cancer linked to an inherited BRCA gene mutation…
Positive LSC status is associated with inferior survival outcomes in patients with acute myeloid leukemia
Leukemia Stem Cell Counts Help Doctors Predict Patient Survival Outcomes
This systematic review and reconstructed individual patient data meta-analysis analyzed survival outcomes in patients with acute myeloid leu…
Testing for specific leukemia stem cells can help doctors predict how well a patient will do during treatment.
Early diverting ileostomy closure shows no significant difference in morbidity compared to delayed closure
Early closure of ileostomy shows no harm for rectal cancer
This meta-analysis of 5 studies involving 512 patients found no statistically significant difference in overall morbidity or severe complica…
New data shows that closing a diverting ileostomy early does not increase complications for patients recovering from rectal cancer surgery.
EGFR p.E709_T710delinsD mutation may present with primary resistance and rapid progression on afatinib
Specific Lung Cancer Mutation May Lead to Rapid Treatment Failure
This case report and literature review describes a patient with stage IV lung adenocarcinoma and an EGFR p.E709_T710delinsD mutation who exp…
A specific mutation in lung cancer may cause patients to progress quickly on afatinib, highlighting the need for early monitoring and testin…
Cancer cachexia is associated with higher odds of postoperative complications in gastrointestinal cancers
Cancer cachexia linked to longer hospital stays and complications
This meta-analysis of 27,473 patients with gastrointestinal cancers found that cancer cachexia is associated with higher odds of postoperati…
Patients with gastrointestinal cancers and cachexia face higher risks of complications and longer hospital stays after surgery.
Ataraxis Breast CTX multi-modal AI model shows HR 1.60 for disease-free survival in breast cancer
AI Model Shows Better Risk Prediction for Breast Cancer
This blinded external validation of a Phase 3 trial evaluated the Ataraxis Breast CTX multi-modal AI model in 677 postmenopausal, node-posit…
A new AI tool combining tissue images with clinical data may help doctors better predict breast cancer recurrence and tailor treatment plans…
Chronic pharyngitis may be reclassified into reproducible biological subgroups to improve targeted treatment strategies
New ways to understand and treat long term throat irritation and infection
This narrative review synthesizes experimental and clinical data regarding the pathophysiology of chronic pharyngitis. The authors argue tha…
Doctors are looking at how different biological factors cause chronic throat issues to help create better treatments for patients.
Specific microRNAs miR-124, miR-34, and miR-506-3p promote differentiation in neuroblastoma cells
MicroRNAs Show Potential in Treating Neuroblastoma Cells
This systematic review of 89 articles examines the role of microRNAs in neuroblastoma cell differentiation. The authors conclude that miR-12…
Specific microRNAs may help neuroblastoma cells mature and could offer a new path for developing future cancer treatments.